# Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/converting-indoprofen-to-moderate-selective-cox-2-inhibitors-design-synthesis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Huifang Lai,Yijie Liang,Jiexin Xu,Lijun Guo,Chenlu Deng,Xiaoping Wang,Daijun Zha |
| Citations | 2 |
| DOI | 10.1016/j.bioorg.2025.108593 |
| Fields | Biochemistry, Genetics and Molecular Biology,Computer Science,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4410398131 |
| PMID | 40393356 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Huifang Lai](https://scholariq.org/researchers/huifang-lai/)

## Paper primary topic

- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)

## Paper topics

- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Eicosanoids and Hypertension Pharmacology](https://scholariq.org/topics/eicosanoids-and-hypertension-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.